Lonza plans bio-pharma facility in Hyderabad

Lonza Group, the Switzerland-based bio-pharmaceutical company plans to infuse $ 150 million (approx Rs 705 crore) in setting up a facility to be located at the outskirts of Hyderabad, Andhra Pradesh.

The facility is expected to be set up in two phases. Phase I will comprise of a small-scale multi-purpose manufacturing plant for biopharmaceuticals, bio-therapeutic media manufacturing plant labs for biologics and bioinformatics etc. Phase II will see the expanded large-scale manufacturing plant for biopharmaceuticals and media manufacturing capacity for bio-therapeutic media.

Phase I and Phase II are expected to be completed between 2011-2013 and 2014-2015 respectively.


Source : ProjectsToday

Printer-Friendly Version E-mail This Article

Loading...